閉経、ホルモン療法、および心血管リスク
Geneviève Plu-Bureau1, Iphigénie Cavadias1, Brigitte Raccah-Tebeka2
1Unité de gynécologie endocrinienne, hôpital Port-Royal, Université Paris Cité, Paris, Inserm UMR 1153, Obstetrical, Perinatal, Paediatric Life course Epidemiology (OPPaLE), centre d'épidémiologie et de statistiques Sorbonne Paris Cité (CRESS), Paris, France.
まとめ
閉経は、女性の心血管疾患リスク要因をスクリーニングするのに理想的な時期です。経皮エストラジオールと天然プロゲステロンは、資格のある女性にとって最も安全なホルモン療法であり、年次のリスク評価が必要です。
科学分野:
- 心臓病学
- 女性の健康
- 内分泌学
背景:
- 心血管疾患(CVD)は、フランスの女性の死因の主要な原因です。
- 閉経は、心血管リスク評価の重要なウィンドウを表します。
- 無能な性周期症候群は、しばしば治療上の考慮を必要とします。
主な方法:
- 閉経期の女性におけるCVDリスク要因に関する現在の臨床ガイドラインと文献のレビュー。
- さまざまなMHT製剤の安全性プロファイルの分析。
- MHT管理のための年次フォローアップの必要性の強調。
結論:
- 閉経中の体系的な心血管リスクスクリーニングは不可欠です。
- 特定のMHT製剤(経皮エストラジオール/天然プロゲステロン)は、選択された女性にとって有利な便益/リスクプロファイルを提供します。
- MHTの安全性と有効性を最適化するには、継続的な監視が不可欠です。
関連する概念動画
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Hormonal Regulation of the Menstrual Cycle
1.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Hormonal Regulation of Blood Pressure
5.8K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.8K
Psychoneuroimmunology: Cardiovascular Disease
382
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
382
Mitral Valve Prolapse III: Nursing Management
279
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
279
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915


